The Cochlear Limited share price just hit a 52 week high

The Cochlear share price is on the move

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Cochlear Limited (ASX: COH) share price has today hit a 52-week high, trading as high as $155.30.

This latest gain means that the bionic ear company's shares have provided shareholders with a year-to-date return of over 26%.

At an investor day last month, Cochlear management reiterated its full-year earnings guidance of between $210 million and $225 million, an increase of between 10% and 20% on last year's result.

Cochlear shares are not exactly cheap, trading at around 40 times forward earnings estimates.

Motley Fool contributor Motley Fool Staff has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Dividend Investing

Hoping to bag the boosted dividend from CSL shares? Here's your deadline…

The ASX 200 biotech is rewarding investors with a 9% higher interim dividend this year.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

2 ASX healthcare shares rated as top buys

Are these two names healthy choices for your portfolio? Let's see.

Read more »

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
Healthcare Shares

Why Mesoblast shares could still be dirt cheap even after 700% gain

This biotech has been on fire but the gains may not be over yet according to Bell Potter.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

The 'crucial' growth metric that makes CSL shares a buy today

A leading expert points to a critical growth metric that could boost CSL shares in 2025.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Healthcare Shares

Guess which ASX 200 biotech stock is jumping 7% on big news

What is getting investors excited today? Let's find out.

Read more »

Shot of a young scientist using a laptop while conducting research in a laboratory.
Healthcare Shares

Why is this ASX 200 healthcare share tanking 10% on Tuesday?

This ASX radiopharmaceutical company's 1H FY25 report appears to have rattled investors.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

Up 810% in a year, the Mesoblast share price is surging again on Monday. Here's why

Investors are piling into Mesoblast shares on Monday. But why?

Read more »

Three Archer Materials scientists wearing white coats and blue gloves dance together in their lab after making a discovery
Healthcare Shares

Up 162% in a year, Pro Medicus share price leaping higher today on major US news

ASX 200 investors are reacting positively to Pro Medicus’ latest US news.

Read more »